CRONOS GROUP INC. (CRON) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
30/68
2.2 / 5 stars
All 68 Win/Lose results and 52 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
LoseCRON / S&P 10.76% / 15.20% |
WinCRON / S&P 37.46% / 15.00% |
WinCRON / S&P 233.33% / 50.40% |
| 2026-Q11/3 |
LoseCRON / S&P -4.56% / -4.33% |
WinCRON / S&P 28.05% / 11.30% |
LoseCRON / S&P -92.86% / 27.70% |
| 2025-Q41/3 |
LoseCRON / S&P -5.40% / 2.65% |
WinCRON / S&P 24.63% / 9.00% |
LoseCRON / S&P -109.09% / 13.40% |
| 2025-Q32/3 |
WinCRON / S&P 45.55% / 8.12% |
WinCRON / S&P 19.00% / 4.61% |
LoseCRON / S&P -191.67% / 13.45% |
| 2025-Q21/3 |
LoseCRON / S&P 5.52% / 10.94% |
WinCRON / S&P 28.01% / 4.83% |
LoseCRON / S&P -142.86% / 10.63% |
| 2025-Q11/3 |
LoseCRON / S&P -10.40% / -4.27% |
WinCRON / S&P 33.92% / 4.98% |
LoseCRON / S&P -200.00% / 10.57% |
| 2024-Q41/3 |
LoseCRON / S&P -7.76% / 2.41% |
WinCRON / S&P 34.82% / 5.25% |
LoseCRON / S&P -161.11% / 6.15% |
| 2024-Q31/3 |
LoseCRON / S&P -6.01% / 5.89% |
WinCRON / S&P 30.31% / 5.89% |
LoseCRON / S&P -57.14% / 6.11% |
| 2024-Q21/3 |
LoseCRON / S&P -10.73% / 4.28% |
WinCRON / S&P 25.71% / 5.38% |
LoseCRON / S&P -63.16% / 5.12% |
| 2024-Q12/3 |
WinCRON / S&P 24.88% / 10.56% |
WinCRON / S&P 11.37% / 5.71% |
LoseCRON / S&P -65.85% / 5.59% |
| 2023-Q40/2 |
LoseCRON / S&P 4.50% / 11.69% |
LoseCRON / S&P -2.06% / 6.81% |
No dataCRON / S&P / 7.78% |
| 2023-Q31/2 |
WinCRON / S&P 1.52% / -3.27% |
LoseCRON / S&P 2.89% / 7.52% |
No dataCRON / S&P / -5.03% |
| 2023-Q20/2 |
LoseCRON / S&P 1.55% / 8.74% |
LoseCRON / S&P -2.42% / 9.50% |
No dataCRON / S&P / -8.57% |
| 2023-Q10/2 |
LoseCRON / S&P -23.62% / 7.50% |
LoseCRON / S&P 8.52% / 10.77% |
No dataCRON / S&P / -15.69% |
| 2022-Q41/2 |
LoseCRON / S&P -9.93% / 7.56% |
WinCRON / S&P 37.97% / 11.88% |
No dataCRON / S&P / -17.99% |
| 2022-Q32/2 |
WinCRON / S&P 0.00% / -4.88% |
WinCRON / S&P 26.31% / 13.47% |
No dataCRON / S&P / -1.41% |
| 2022-Q21/2 |
LoseCRON / S&P -27.51% / -16.10% |
WinCRON / S&P 46.48% / 13.71% |
No dataCRON / S&P / 11.04% |
| 2022-Q12/2 |
WinCRON / S&P -0.77% / -4.60% |
WinCRON / S&P 51.25% / 15.97% |
No dataCRON / S&P / 42.23% |
| 2021-Q41/2 |
LoseCRON / S&P -30.74% / 11.03% |
WinCRON / S&P 38.19% / 15.00% |
No dataCRON / S&P / 96.40% |
| 2021-Q31/2 |
LoseCRON / S&P -34.19% / 0.58% |
WinCRON / S&P 77.62% / 10.77% |
No dataCRON / S&P / 69.42% |
| 2021-Q21/2 |
LoseCRON / S&P -9.09% / 8.55% |
WinCRON / S&P 80.33% / 6.58% |
No dataCRON / S&P / 51.81% |
| 2021-Q12/3 |
WinCRON / S&P 36.31% / 6.17% |
WinCRON / S&P 74.44% / -1.06% |
LoseCRON / S&P -119.82% / 7.39% |
| 2020-Q42/3 |
WinCRON / S&P 38.52% / 12.15% |
WinCRON / S&P 96.71% / -3.72% |
LoseCRON / S&P -105.09% / -33.42% |
| 2020-Q30/1 |
LoseCRON / S&P -16.64% / 8.93% |
No dataCRON / S&P / -2.04% |
No dataCRON / S&P / -27.10% |
| 2020-Q20/1 |
LoseCRON / S&P 6.00% / 20.54% |
No dataCRON / S&P / -0.46% |
No dataCRON / S&P / -27.11% |
| 2020-Q10/1 |
LoseCRON / S&P -26.08% / -19.60% |
No dataCRON / S&P / 3.47% |
No dataCRON / S&P / -14.75% |
| 2019-Q40/1 |
LoseCRON / S&P -15.25% / 9.07% |
No dataCRON / S&P / 5.36% |
No dataCRON / S&P / 2.99% |
| 2019-Q30/1 |
LoseCRON / S&P -43.37% / 1.70% |
No dataCRON / S&P / 5.02% |
No dataCRON / S&P / 0.21% |
| 2019-Q20/1 |
LoseCRON / S&P -13.29% / 4.30% |
No dataCRON / S&P / 6.64% |
No dataCRON / S&P / 8.65% |
| 2019-Q11/1 |
WinCRON / S&P 77.38% / 13.65% |
No dataCRON / S&P / 8.12% |
No dataCRON / S&P / 14.29% |
| 2018-Q41/1 |
WinCRON / S&P -6.56% / -13.52% |
No dataCRON / S&P / 9.05% |
No dataCRON / S&P / 18.23% |
| 2018-Q31/1 |
WinCRON / S&P 70.55% / 7.71% |
No dataCRON / S&P / 10.21% |
No dataCRON / S&P / 19.06% |
| 2018-Q20/1 |
LoseCRON / S&P -3.12% / 3.43% |
No dataCRON / S&P / 9.03% |
No dataCRON / S&P / 14.46% |
| 2018-Q10/0 |
No dataCRON / S&P / -0.76% |
No dataCRON / S&P / 7.68% |
No dataCRON / S&P / 12.46% |
| 2017-Q40/0 |
No dataCRON / S&P / 6.64% |
No dataCRON / S&P / 7.03% |
No dataCRON / S&P / 13.82% |
| 2017-Q30/0 |
No dataCRON / S&P / 4.48% |
No dataCRON / S&P / 5.68% |
No dataCRON / S&P / 17.57% |
| 2017-Q20/0 |
No dataCRON / S&P / 3.09% |
No dataCRON / S&P / 4.83% |
No dataCRON / S&P / 17.74% |
| 2017-Q10/0 |
No dataCRON / S&P / 6.07% |
No dataCRON / S&P / 3.67% |
No dataCRON / S&P / 13.32% |
| 2016-Q40/0 |
No dataCRON / S&P / 3.82% |
No dataCRON / S&P / 2.09% |
No dataCRON / S&P / 7.05% |
| 2016-Q30/0 |
No dataCRON / S&P / 3.85% |
No dataCRON / S&P / 0.20% |
No dataCRON / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CRON total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 30.38% | 20.78% |
| Annualized return | 30.38% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CRON total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -47.60% | 83.14% |
| Annualized return | -12.13% | 12.86% |
10Y · 2018-02-27 to 2026-08-27
| Metric | CRON total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -55.51% | 319.30% |
| Annualized return | -7.78% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |